<body><div><figure><img src="https://img.particlenews.com/image.php?type=thumbnail_580x000&amp;url=4X1jdE_1FGw0qhy00" alt="https://img.particlenews.com/image.php?url=4X1jdE_1FGw0qhy00" width="1250" height="778" ></figure>UnityPoint Health® – Trinity Heart Center has become the first health system in the Quad Cities to use a new FDA-approved technology to treat patients with atrial fibrillation (AFib), the most common type of heart rhythm disorder.Electrophysiologists and care teams at Trinity Heart Center performed the first successful pulsed field ablation (PFA) procedure using Abbott's Volt™ PFA System on September 3, 2026, at Trinity Heart Center in Rock Island, Illinois."We're proud to offer another advanced treatment option for patients with AFib, allowing them to receive leading-edge heart care close to home," says Kathy Pulley, director of cardiology services at UnityPoint Health – Trinity. "Bringing innovative technologies like this to our community reflects our commitment to providing the highest level of heart care while continuing to lead the way in heart health across the region."<figure><img src="https://img.particlenews.com/image.php?type=thumbnail_580x000&amp;url=2FVir4_1FGw0qhy00" alt="https://img.particlenews.com/image.php?url=2FVir4_1FGw0qhy00" width="1250" height="985" ></figure>Trinity Heart Center is the first in the region to use Abbott's Volt PFA system. While the Volt system is new to the organization, Trinity Heart Center has been performing pulsed field ablation procedures since April 2024, when it became the first in the Quad Cities to offer the treatment.Pulsed field ablation uses high-energy electrical pulses to ablate the heart tissue causing irregular heart rhythms without using excess heat or cold, which has the potential to damage surrounding tissue. Designed to fit each patient's heart anatomy, the Volt system allows physicians to map and treat abnormal heart rhythms with a single catheter, reducing procedure time."The growing use of PFA technology is delivering encouraging results for patients with AFib," says Mark Shen, MD, cardiac electrophysiologist and cardiologist at UnityPoint Health – Trinity. "One of its greatest advantages is its ability to precisely target the tissue causing the abnormal heart rhythm while minimizing effects on nearby structures. By using an innovative balloon design, this system conforms naturally to the heart's anatomy, allowing us to treat targeted areas more efficiently and predictably, often leading to quicker procedure times. For many patients, that means improved AFib symptoms and better quality of life."AFib affects an estimated 10 and half million Americans and increases the risk of stroke, heart failure, and death, if left untreated.People with AFib should discuss the PFA treatment option with their cardiologist or call Trinity Heart Center at (309) 779-5340. Find more information on heart and vascular care, visit unitypoint.org.</div></body>

Block Source: midwestmedicaledition.com

Misinformation

Clickbait

Old or repetitive news

Explicit content

Location not relevant

UnityPoint Health® – Trinity Heart Center has become the first health system in the Quad Cities to use a new FDA-approved technology to treat patients with atrial fibrillation (AFib), the most common type of heart rhythm disorder. Electrophysiologists and care teams at Trinity Heart Center performed the first...

UnityPoint Health Trinity First in Quad Cities With New AFib Technology

NewsBreak

UnityPoint Health® – Trinity Heart Center has become the first health system in the Quad Cities to use a new FDA-approved technology to treat patients with

UnityPoint Health Trinity First in Quad Cities With New AFib Technology

Comments